Samsung Bioepis Backed By EMA For First Lucentis Biosimilar

Byooviz Ranibizumab Biosimilar Recommended By EMA’s CHMP

 
• By Dean Rudge
  
Eye
Byooviz will be sold in Europe by Biogen • Source: Shutterstock

More from Regulation

More from Policy & Regulation